Protemix Corporation Limited

Calculating rank

USPTO Granted Patents = 8

% Expired Patents = 37.5

Forward Citations = 130

Loading Chart...

9 inventors (with patents filed for the assignee):

John Richard Baker (5 out of 11 patents)

Garth J S Cooper (3 out of 8 patents)

Yu Wang (2 out of 8 patents)

4. Aimin Xu (2 out of 5 patents)

5. Irene Vaulont (1 out of 7 patents)

6. Marco Jonas (1 out of 6 patents)

7. Antonio Soi (1 out of 6 patents)

8. Gunther Schmidt (1 out of 12 patents)

9. Garth Cooper (1 out of 2 patents)

8 patents: Sort by Forward Citations

1. 7582796 - Synthesis of triethylenetetramines (2009-09-01),

2. 7365170 - Adiponectin and uses thereof (2008-04-29),

3. 6951890 - Preventing and/or treating cardiovascular disease and/or associated heart failure (2005-10-04),

4. 6897243 - Fructosamine oxidase: antagonists and inhibitors (2005-05-24),

5. 6884575 - Phosphoprotein target for insulin and its antagonists (2005-04-26),

6. 6855511 - Fructosamine oxidase assay: methods and materials (2005-02-15),

7. 6610693 - Fructosamine oxidase: antagonists and inhibitors (2003-08-26),

8. 6348465 - Fructosamine oxidase: antagonists and inhibitors (2002-02-19),

Company Overview

Protemix Corporation Limited is a biotechnology company dedicated to developing innovative solutions for metabolic disorders. Their research focuses on utilizing protein engineering and drug delivery technologies to create targeted therapies for conditions such as diabetes and obesity. With a team of experienced scientists and industry experts, Protemix is committed to making a meaningful impact on the lives of patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

8 Patents

#4 in

#92 in New Zealand

NZ